Skip to content
lifestyle.womensconference.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Opus Genetics, Inc.
Opus Genetics Announces FDA Acceptance of Supplemental New Drug Application for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
February 25, 2026
Opus Genetics Announces $25 Million Private Placement
February 13, 2026
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
February 9, 2026
←
Previous Page
1
2
3